XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value Measures and Disclosures (Tables)
9 Months Ended
Sep. 30, 2022
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The Company’s assets and liabilities that were measured at fair value on a recurring basis were as follows:
Fair Value Measured as of September 30, 2022
Level 1Level 2Level 3Total
(In thousands)
Assets
Money market funds (i)$39,215 $— $— $39,215 
U.S. Treasury securities (ii)35,131 — — 35,131 
Corporate bonds (ii)— 37,347 — 37,347 
Total financial assets$74,346 $37,347 $— $111,693 
Liabilities
Common stock warrant liabilities (Public) (iii)$6,986 $— $— $6,986 
Common stock warrant liabilities (Private Placement) (iii)— — 3,605 3,605 
Common stock warrant liabilities (2022 Private Warrant) (iii)245 245 
Contingent earnout liabilities— — 53,377 53,377 
Total financial liabilities$6,986 $— $57,227 $64,213 
Fair Value Measured as of December 31, 2021
Level 1Level 2Level 3Total
(In thousands)
Assets
Money market funds (i)$207,471 $— $— $207,471 
U.S. Treasury securities (ii)8,141 — — 8,141 
Corporate bonds (ii)— 7,342 — 7,342 
Total financial assets$215,612 $7,342 $— $222,954 
Liabilities
Common stock warrant liabilities (Public) (iii)$14,318 $— $— $14,318 
Common stock warrant liabilities (Private Placement) (iii)— — 7,387 7,387 
Contingent earnout liabilities— — 111,487 111,487 
Total financial liabilities$14,318 $— $118,874 $133,192 
(i)     Included in cash and cash equivalents on the condensed consolidated balance sheets.
(ii)     Included in short-term investments on the condensed consolidated balance sheets.
(iii)    Included in warrant liabilities on the condensed consolidated balance sheets.
Summary of Changes in Fair Value of Level 3 Financial Instruments
The following table presents a rollforward of the Level 3 assets and liabilities measured at fair value on a recurring basis:
Redeemable convertible preferred stock warrant liabilitiesPrivate placement warrant liabilities2022 Private WarrantContingent earnout liabilities
(In thousands)
Three Months Ended September 30, 2022
Fair value as of June 30, 2022$— $1,380 $— $12,492 
Issuance of warrant— — 170 — 
Change in fair value— 2,225 75 40,885 
Fair value as of September 30, 2022$— $3,605 $245 $53,377 
Nine months ended September 30, 2022
Fair value as of January 1, 2022$— $7,387 $— $111,487 
Issuance of warrant— — 170— 
Change in fair value— (3,782)75 (58,110)
Fair value as of September 30, 2022$— $3,605 $245 $53,377 
Three Months Ended September 30, 2021
Fair value as of June 30, 2021$1,922 $— $— $— 
Private placement warrant liabilities acquired as part of the reverse recapitalization— 7,165 — — 
Contingent earnout liabilities recognized upon the closing of the reverse recapitalization— — — 120,763 
Exercise of warrants(899)— — — 
Change in fair value(1,023)(312)— (2,014)
Fair value as of September 30, 2021$— $6,853 $— $118,749 
Nine months ended September 30, 2021
Fair value as of January 1, 2021$181 $— $— $— 
Private placement warrant liabilities acquired as part of the reverse recapitalization— 7,165 — — 
Contingent earnout liabilities recognized upon the closing of the reverse recapitalization— — — 120,763 
Exercise of warrants(899)— — — 
Change in fair value718 (312)— (2,014)
Fair value as of September 30, 2021$— $6,853 $— $118,749